250
Views
88
CrossRef citations to date
0
Altmetric
Review

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft Mist Inhaler

&
Pages 381-390 | Published online: 14 Oct 2009

References

  • MacNeeWPathogenesis of Chronic Obstructive Pulmonary DiseaseProc Am Thorac Soc20052425826616267346
  • CalverleyPMInhaled corticosteroids are beneficial in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016134134210673165
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the diagnosis, management and prevention of chronic obstructive pulmonary diseaseBethesdaNational Institute of Health, National Heart, Lung, and Blood Institute2003 NHLBI/WHO Workshop Report.
  • SinDDMcAlisterFAManSFContemporary management of chronic obstructive pulmonary disease: scientific reviewJAMA20032902301231214600189
  • CelliBRThomasNEAndersonJAEffect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH StudyAm J Respir Crit Care Med20081784332338
  • SuissaSErnstPVandemheenKLAaronSDMethodological issues in therapeutic trials of COPDEur Respir J20083192793318216056
  • TashkinDPCelliBSennSfor the UPLIFT Study InvestigatorsA 4 year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
  • DecramerMCelliBKestenSLystigTMehraSTashkinDFor the UPLIFT investigators. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomized controlled trialLancet Published online August 28, 2009; DOI:10.1016/S0140-6736(09)61298-8.
  • NewmanSPInhaler treatment options in COPDEur Resp Rev200514102108
  • CromptonGKProblems patients have using pressurized aerosol inhalersEur J Respir Dis Suppl19821191011046954081
  • LindgrenSBakeBLarssonSClinical consequences of inadequate inhalation technique in asthma therapyEur J Respir Dis19877093983817076
  • GiraudVRocheNMisuse of corticosteroid metered-dose inhaler is associated with decreased asthma stabilityEur Respir J20021924625111866004
  • PedersenSFrostLArnfredTErrors in inhalation technique and efficiency in inhaler use in asthmatic childrenAllergy1986411181243706674
  • BatemanEDImproving inhaler use in COPD and the role of patient preferenceEur Respir Rev2005148588
  • OsmanLMHylandMEPatient needs and medication styles in COPDEur Respir Rev200514968992
  • AndersonPJPatient preferences for and satisfaction with inhaler devicesEur Respir Rev20051496109116
  • HodderRDesign and interpretation of device preference trials: marketing tools or scientific instruments?Respiratory Drug Delivery2006X1936
  • JonesRHylandMEHanneyKA qualitative study of compliance with medication and lifestyle modification in chronic obstructive pulmonary disease (COPD)Prim Care Respir J20041314915416701658
  • RandCSPatient adherence with COPD therapyEur Respir Rev2005149697101
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med200535348749716079372
  • BrocklebankDRamFWrightJComparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literatureHealth Technol Assess20015114911701099
  • DolovichMAhrensRCHessDDevice selection and outcomes of aerosol therapy: Evidence-based guidelinesChest200512733537115654001
  • PriceDThomasMMitchellGImprovement of asthma control with a breath-actuated pressurised metered dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metered dose inhaler (MDI) or a breath-actuated deviceRespir Med200397121912556005
  • ThomasMPriceDChrystynHInhaled corticosteroids for asthma: impact of practice level device switching on asthma controlBMC Pulm Med200991 URL: http://www.biomedcentral.com/1471-2466/9/1.19121204
  • TjwaMKTBudesonide inhaled via Turbuhaler: a more effective treatment for asthma than beclomethasone dipropionate via RotahalerAnn Allergy Asthma Immunol1995751071117648372
  • FletcherMHardyAJKarbalBEffects of asthma training on inhaler device selection and utilization in general practiceEur Respir J200424Suppl 48257s
  • SchürmannWSchmidtmannSMoroniPRespimat® Soft Mist™ inhaler versus hydrofluoroalkane metered dose inhaler: Patient preference and satisfactionTreat Respir Med20054536115725050
  • LenneyJInnesJACromptonGKInappropriate inhaler use: assessment of use and patient preference of seven inhalation devicesRespir Med20008449650010868714
  • BourbeauJBartlettSJPatient adherence in COPDThorax20086383183818728206
  • RandCSNidesMCowlesMLong-term metered dose inhaler adherence in a clinical trial. The Lung Health Study Research GroupAm J Respir Crit Care Med19951525805887633711
  • BalkrishnanRChristensenDInhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary diseaseClin Ther20002245246910823366
  • CanonicaGBaena-CagnaniCBlaissMUnmet needs in asthma. Global Asthma Physician and Patient (GAPP) survey: global adult findingsAllergy20076266867417508972
  • AdamsRFuhlbriggeAGuilbertTInadequate use of asthma medication in the United states: results of the Asthma in America national population surveyJ Allergy Clin Immunol2002110586412110821
  • RabeKAdachiMLaiCWorldwide severity and control of asthma in children and adults: the global asthma insights and reality surveysJ Allergy Clin Immunol2004114404715241342
  • CordenZBosleyCReesPHome nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of lifeChest1997112127812829367468
  • HochrainerDHölzHKreherCComparison of the aerosol velocity and spray duration of Respimat® Soft Mist™ inhaler and pressurized metered dose inhalersJ Aerosol Med20051827328216181002
  • NewmanSPUse of gamma scintigraphy to evaluate the performance of new inhalersJ Aerosol Med199912Suppl 1S25S3110623338
  • PitcairnGReaderSJPaviaDDeposition of corticosteroid aerosol in the human lung by Respimat® Soft Mist™ inhaler compared to deposition by metered dose inhaler or by Turbuhaler® dry powder inhalerJ Aerosol Med200518S264S272
  • KässnerFHodderRBatemanEDA review of ipratropium bromide/fenoterol hydrobromide (Berodual®) delivered via Respimat® Soft Mist™ Inhaler in patients with asthma and chronic obstructive pulmonary diseaseDrugs2004641671168215257628
  • BrandPHedererBAustenGHigher lung deposition with Respimat Soft Mist Inhaler than HFA-MDI in COPD patients with poor techniqueInt J Chron Obstruct Pulmon Dis2008376377019281091
  • AtkinsonMJSinhaAHassSLValidation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth Qual Life Outcomes200421214987333
  • ShikiarRRentzAMSatisfaction with medication: an overview of conceptual, methodologic, and regulatory issuesValue Health2004720421515164810
  • WelchMJComparison of patient preference and ease of teaching inhaler technique for pulmicort Turbuhaler® versus pressurized metered-dose inhalersJ Aerosol Med20041712913915294063
  • KozmaCMSlatonTLMonzBUDevelopment and validation of a patient satisfaction and preference questionnaire for inhalation devicesTreat Respir Med20054415215725049
  • MonzBKozmaCReesePSlatonTHodderRPatient Satisfaction and Preference Questionnaire (PASAPQ) User Manual Copyright, Boehringer Ingelheim International GmbH, 2005. [email protected].
  • KardosPGolischWWolfKNew soft mist inhaler is effective and easy to use in patients with asthma and COPD [abstract]Eur Respir J200526Suppl 49338s
  • FreytagFGolischWWolfKCOPD and asthma patients are satisfied with handling and inhalation characteristics of Soft Mist™ (Berodual® Respimat®Eur Respir J200628Suppl 50739s
  • HodderRReesePRSlatonTAsthma patients prefer Respimat® Soft Mist™ Inhaler to Turbuhaler®Int J COPD20094225232
  • FreytagFRau-BergerHGlaabTRespimat® Soft Mist™ Inhaler preferred to Diskus by patients with COPD and/or asthmaAm J Respir Crit Care Med2007175A639
  • StoloffSWStempelDAMeyerJImproved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapiesJ Allergy Clin Immunol200411324525114767437
  • O’ConnorRDRosenzweigJRStanfordRHAsthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimensAnn Allergy Asthma Immunol20059553554016400892
  • SuissaSMedications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signsAm J Respir Crit Care Med2008178432232318676961